Conmed (CNMD) shares are nearing decade lows despite credible progress with supply issues and ongoing efforts to shift toward ...

PROSY's high expected double-digit revenue and earnings growth should act as a driver for strong stock gains over the ...

One of the common rationales of any M&A deal is that the combined enterprise will generate a higher growth rate and perform ...

QUAL is pretty big and larger than SPHQ and JQUA. QUAL has a similar return to the other ETFs in 2025, though they are all ...

Discover why ARC Resources (AETUF) is a strong buy, maintaining profitable growth and low debt after acquisition.

Nextpower is expanding from solar trackers into a broader utility-scale solar platform. Click here to read more about NXT ...

Transocean (RIG) has surged 42.9% recently, outperforming the S&P 500, yet I maintain a 'hold' rating due to lingering risks.

Quantum eMotion is a cybersecurity firm applying quantum innovations to the cybersecurity market. Read why I view QNCCF stock ...

Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

Burry's likely right about depreciation. The way that always ends is the Company takes a one time non-cash, non-operating ...

Discover why Equinox Gold (EQX) is rated a Buy for 2026, driven by production growth, falling costs, and strong Q3 results.

California BanCorp.'s $3.0B loan portfolio is 58.6% commercial real estate, with the majority of that loan segment being ...